乳腺癌幸存者冠状动脉放射剂量与需干预的冠状动脉狭窄位置的关系
该研究纳入1992至2012年间在瑞典接受三维适形放疗的182例乳腺癌女性,基于原始计划CT重建冠状动脉剂量,并从SCAAR登记识别需干预的狭窄位置。左前降支中段平均剂量>20 Gy者后期该部位冠状动脉干预的校正OR为5.23(95%CI 2.01-13.6),高于0-1 Gy者。作者认为应尽量降低左前降支剂量。
要点
- 左前降支中段平均剂量>20 Gy者后期该部位冠状动脉干预风险升高,校正OR 5.23(95%CI 2.01-13.6)。
- 左前降支中段平均剂量1-5 Gy者校正OR 0.90(95%CI 0.47-1.74),5-20 Gy者校正OR 1.24(95%CI 0.52-2.95)。
- 作者认为放疗计划中应考虑左前降支剂量并尽量保持低剂量。
核心结论
- 在1992至2012年间接受常规三维适形放疗的乳腺癌女性中,左前降支受到的放射剂量仍较高,且与左前降支中段后期需要冠状动脉干预的风险增加相关。
- 作者认为结果支持在放疗治疗计划中考虑左前降支剂量并尽量保持低剂量,最小化左前降支剂量预期可降低后期放射性狭窄风险。
研究设计与样本
- 研究人群为1992至2012年间在瑞典接受乳腺癌治疗的182例女性,均接受三维适形放疗并随后因疑似冠状动脉事件接受冠状动脉造影。
- 在患者原始计划CT上勾画冠状动脉节段,并根据原始放疗计划的剂量分布重新计算放射剂量。
- 需干预的冠状动脉狭窄位置从瑞典冠状动脉造影和血管成形术登记(SCAAR)识别,采用逻辑回归分析冠状动脉放射剂量与后期该特定位置冠状动脉干预风险的关系。
主要发现
- 左前降支中段放射剂量与后期该部位冠状动脉干预风险的比值比(OR)随剂量变化(p = 0.005)。
- 与左前降支中段平均剂量0-1 Gy者相比,平均剂量1-5 Gy者后期冠状动脉干预的校正OR为0.90(95%CI 0.47-1.74)。
- 与左前降支中段平均剂量0-1 Gy者相比,平均剂量5-20 Gy者校正OR为1.24(95%CI 0.52-2.95)。
- 与左前降支中段平均剂量0-1 Gy者相比,平均剂量超过20 Gy者校正OR为5.23(95%CI 2.01-13.6)。
临床怎么用
- 作者认为左前降支放射剂量应纳入放疗治疗计划考虑,且剂量应尽量保持低。
- 作者认为最小化左前降支剂量预期可降低后期放射性狭窄风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess the relationship between radiation doses to the coronary arteries (CAs) and location of a coronary stenosis that required intervention after three-dimensional conformal radiotherapy (3DCRT) for breast cancer (BC). METHODS: The study population consisted of 182 women treated for BC in Sweden between 1992 and 2012. All women received 3DCRT and subsequently underwent coronary angiography due to a suspected coronary event. CA segments were delineated in the patient's original planning-CT and radiation doses were recalculated based on the dose distribution of the original radiotherapy (RT) plan. The location of the CA stenosis that required intervention was identified from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Logistic regression analysis was used to assess the relationship between CA radiation doses and risk of a later coronary intervention at this specific location. RESULTS: The odds ratio (OR) varied by radiation dose to the mid left anterior descending artery (LAD) (p = 0.005). Women receiving mean doses of 1-5 Gray (Gy) to the mid LAD had an adjusted OR of 0.90 (95% CI 0.47-1.74) for a later coronary intervention compared to women receiving mean doses of 0-1 Gy to the mid LAD. In women receiving mean doses of 5-20 Gy to the mid LAD, an adjusted OR of 1.24 (95% CI 0.52-2.95) was observed, which increased to an OR of 5.23 (95% CI 2.01-13.6) for mean doses over 20 Gy, when compared to women receiving mean doses of 0-1 Gy to the mid LAD. CONCLUSIONS: In women receiving conventional 3DCRT for BC between 1992 and 2012, radiation doses to the LAD remained high and were associated with an increased requirement of coronary intervention in mid LAD. The results support that the LAD radiation dose should be considered in RT treatment planning and that the dose should be kept as low as possible. Minimising the dose to LAD is expected to diminish the risk of later radiation-induced stenosis.
引用
- Wennstig AK, Garmo H, Isacsson U, et al. The relationship between radiation doses to coronary arteries and location of coronary stenosis requiring intervention in breast cancer survivors. Radiat Oncol. 2019. PMID: 30845947. doi:10.1186/s13014-019-1242-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。